全文获取类型
收费全文 | 2087篇 |
免费 | 119篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 137篇 |
妇产科学 | 73篇 |
基础医学 | 291篇 |
口腔科学 | 55篇 |
临床医学 | 186篇 |
内科学 | 549篇 |
皮肤病学 | 31篇 |
神经病学 | 183篇 |
特种医学 | 189篇 |
外国民族医学 | 1篇 |
外科学 | 151篇 |
综合类 | 58篇 |
预防医学 | 94篇 |
眼科学 | 53篇 |
药学 | 73篇 |
中国医学 | 4篇 |
肿瘤学 | 79篇 |
出版年
2023年 | 7篇 |
2022年 | 14篇 |
2021年 | 41篇 |
2020年 | 25篇 |
2019年 | 50篇 |
2018年 | 55篇 |
2017年 | 45篇 |
2016年 | 45篇 |
2015年 | 47篇 |
2014年 | 76篇 |
2013年 | 91篇 |
2012年 | 120篇 |
2011年 | 101篇 |
2010年 | 84篇 |
2009年 | 96篇 |
2008年 | 111篇 |
2007年 | 103篇 |
2006年 | 91篇 |
2005年 | 65篇 |
2004年 | 69篇 |
2003年 | 51篇 |
2002年 | 62篇 |
2001年 | 44篇 |
2000年 | 61篇 |
1999年 | 38篇 |
1998年 | 48篇 |
1997年 | 41篇 |
1996年 | 42篇 |
1995年 | 42篇 |
1994年 | 36篇 |
1993年 | 27篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 15篇 |
1989年 | 31篇 |
1988年 | 32篇 |
1987年 | 20篇 |
1986年 | 26篇 |
1985年 | 24篇 |
1984年 | 27篇 |
1983年 | 22篇 |
1982年 | 14篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1979年 | 14篇 |
1978年 | 13篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1974年 | 6篇 |
1969年 | 6篇 |
排序方式: 共有2214条查询结果,搜索用时 15 毫秒
81.
82.
Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells 总被引:2,自引:1,他引:2
Using two different approaches, we have investigated the types of G proteins coupled to CC chemokine receptors. First, permeabilization of interleukin-2-activated natural killer (IANK) cells with streptolysin-O and introduction of anti-G protein antibodies inside these cells resulted in the following. (1) Anti-G(s), anti-G(o), and anti-G(z) inhibited the migration of IANK cells in response to macrophage- inflammatory protein-1 alpha (MIP-1 alpha), monocyte chemoattractant protein-1 (MCP-1), or regulated on activation normal T cell expressed and secreted (RANTES). (2) Anti-Gi inhibited their migration in response to MCP-1 or RANTES but not in response to MIP-1 alpha. Second, incubation of IANK cell membranes with anti-G protein antibodies before incubating with (gamma-35S) GTP or (gamma-32P) GTP, resulted in the following. (1) Anti-G(s), anti-G(o), or anti-G(z) inhibited GTP binding and GTPase activity in the presence of MIP-1 alpha, or RANTES. (2) Anti- G(i) inhibited GTP binding and GTPase activity in the presence of MCP-1 or RANTES but not in the presence of MIP-1 alpha. The inhibitory effect of anti-G protein antibodies was reversed upon incubating these antibodies with their respective synthetic peptides before addition to IANK cell membranes. These results suggest that MCP-1 and RANTES receptors are promiscuously coupled to multiple G proteins in IANK cell membranes and that this coupling is different from MIP-1 alpha receptors, which seem to be coupled to G(s), G(o), and G(z) but not to G(i). 相似文献
83.
Cardoso AA; Schultze JL; Boussiotis VA; Freeman GJ; Seamon MJ; Laszlo S; Billet A; Sallan SE; Gribben JG; Nadler LM 《Blood》1996,88(1):41-48
Even if neoplastic cells express tumor associated antigens they still may fail to function as antigen presenting cells (APC) if they lack expression of one or more molecules critical for the induction of productive immunity. These cellular defects can be repaired by physiologic activation, transfection, or fusion of tumor cells with professional APC. Although such defects can be repaired, antitumor specific T cells may still fail to respond in vivo if they may have been tolerized. Here, human pre-B cell acute lymphoblastic leukemia (pre-B ALL) was used as a model to determine if primary human tumor cells can function as alloantigen presenting cells (alloAPC) or alternatively whether they induce anergy. In the present report, we show that pre-B cell ALL express alloantigen and adhesion molecules but uniformly lack B7-1 (CD80) and only a subset express B7-2 (CD86). Pre-B ALL cells are inefficient or ineffective alloAPC and those cases that lack expression of B7-1 and B7-2 also induce alloantigen specific T- cell unresponsiveness. Under these circumstances, T-cell unresponsiveness could be prevented by physiologic activation of tumor cells via CD40, cross-linking CD28, or signaling through the common gamma chain of the interleukin-2 receptor on T cells. Taken together, these results suggest that pre-B ALL may be incapable of inducing clinically significant T-cell-mediated antileukemia responses. This defect may be not only due to their inability to function as APC, but also due to their potential to induce tolerance. Attempts to induce clinically significant antitumor immune responses may then require not only mechanisms to repair the antigen presenting capacity of the tumor cells, but also reversal of tolerance. 相似文献
84.
Porrata LF Litzow MR Inwards DJ Gastineau DA Moore SB Pineda AA Bundy KL Padley DJ Persky D Ansell SM Micallef IN Markovic SN 《Bone marrow transplantation》2004,33(3):291-298
Absolute lymphocyte count at day 15 (ALC-15) after autologous peripheral blood hematopoietic stem cell transplantation (APHSCT) is an independent prognostic factor for survival in non-Hodgkin's lymphoma (NHL). Factors affecting ALC-15 remain unknown. We hypothesized that dose of infused autograft lymphocytes (A-ALC) directly impacts upon ALC-15. A total of 190 consecutive NHL patients received A-ALC between 1993 and 2001. The primary end point was correlation between A-ALC and ALC-15. A strong correlation was identified (r=0.71). A higher A-ALC was infused into patients achieving an ALC-15 > or =500/microl vs ALC-15 <500/microl (median of 0.68 x 10(9)/kg (0.04-2.21 x 10(9)/kg), vs 0.34 x 10(9)/kg (0.04-1.42 x 10(9)/kg), P<0.0001). The median follow-up for all patients was 36 months (maximum of 109 months). The A-ALC threshold was determined at 0.5 x 10(9)/kg. The median overall survival (OS) and progression-free survival (PFS) times were longer in patients who received an A-ALC >/=0.5 x 10(9)/kg vs A-ALC <0.5 x 10(9)/kg (76 vs 17 months, P<0.0001; 49 vs 10 months, P<0.0001, respectively). Multivariate analysis demonstrated A-ALC to be an independent prognostic indicator for OS and PFS. These data support our hypothesis that ALC-15 and survival are dependent upon the dose of infused A-ALC in NHL. 相似文献
85.
Francesco Vairo Emanuele Nicastri Salma Masauni Yussuf Angela Cannas Silvia Meschi Mwanakheir AA Mahmoud Azza H. Mohamed Paul Mohamed Maiko Pasquale De Nardo Nazario Bevilacqua Concetta Castilletti Antonino Di Caro Vincenzo Racalbuto Giuseppe Ippolito 《Emerging infectious diseases》2014,20(3):465-468
We conducted a seroprevalence survey among 500 healthy adult donors at Zanzibar National Blood Transfusion Services. Dengue virus IgG seroprevalence was 50.6% and independently associated with age and urban residence. These data will aid in building a surveillance, preparedness, and response plan for dengue virus infections in the Zanzibar Archipelago.Key words: dengue, seroprevalence, Zanzibar, viruses, vector-borne infections 相似文献
86.
87.
María del Mar lvarez‐Torres Javier Juan‐Albarracín Elies Fuster‐Garcia Fuensanta Bellvís‐Bataller David Lorente Gaspar Reyns Jaime Font de Mora Fernando Aparici‐Robles Carlos Botella Jose Muoz‐Langa Raquel Faubel Sabina Asensio‐Cuesta Germn A. García‐Ferrando Eduard Chelebian Cristina Auger Jose Pineda Alex Rovira Laura Oleaga Enrique Moll‐Olmos Antonio J. Revert Luaba Tshibanda Girolamo Crisi Kyrre E. Emblem Didier Martin Paulina Due‐Tnnessen Torstein R. Meling Silvano Filice Carlos Sez Juan M. García‐Gmez 《Journal of magnetic resonance imaging : JMRI》2020,51(5):1478-1486
88.
F Bonilla-Abadía J F Betancurt J C Pineda J D Vélez G J Tobón C A Cañas 《Clinical rheumatology》2014,33(3):415-418
New cases of Pneumocystis jirovecii pneumonia (PJP) have recently been reported in patients with systemic lupus erythematosus (SLE) after rituximab therapy. Several factors may contribute to susceptibility to P. jirovecii infection in this type of patients, including the immunological characteristics of the disease, the mechanisms of rituximab action, environmental factors, and the biological characteristics of the fungus. We report two patients with SLE who developed PJP after rituximab therapy. 相似文献
89.
Salgado-Galicia Norma Alicia Hernández-Doño Susana Ruiz-Gómez Daniela Jakez-Ocampo Juan Zúñiga Joaquín Vargas-Alarcón Gilberto Acuña Víctor Hernández María Teresa Márquez-García José Eduardo García-Lechuga Maricela Llorente Luis Lima Guadalupe Pineda Carlos Yu Neng Yunis Edmond Granados Julio 《Clinical rheumatology》2020,39(7):2151-2161
Clinical Rheumatology - Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disorder for which Major Histocompatibility Complex (MHC) genes are well-identified as risk factors. SLE... 相似文献
90.